Car T Therapy Market Size And Share

  • Report Code : TIPRE00003731
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

CAR-T Therapy Market Size, Share, and Growth - 2031

Buy Now

CAR-T Therapy Market Report CAR-T Therapy Market Scope and Analysis CAR-T Therapy Market Size and Share

CAR-T Therapy Market Report Analysis

CAR-T Therapy Market

  • CAGR (2025 - 2031)
    16.2%
  • Market Size 2024
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Novartis International AG
  • Kite Pharma Inc Gilead Sciences Inc
  • Juno Therapeutics Celgene Corporation
  • Bluebird Bio Inc Celgene Corporation
  • Sorrento Therapeutics Inc
  • Mustang Bio Inc
  • Aurora Biopharma Inc
  • Legend Biotech Genscript Biotech Corporation
  • Pfizer Inc

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

By Targeted Antigen
  • CD 19
  • BCMA
  • HER2
  • GD2
  • CD 20
  • CD22
  • CD30
  • CD33
  • HER1 and Others
By Therapeutic Application
  • Acute Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia
  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma
  • Multiple Myeloma
  • Glioblastoma
  • Sarcoma
  • Neuroblastoma
  • Acute Myeloid Leukemia
  • Breast Cancer
  • Pancreatic Cancer
  • Hepatocellular Carcinoma
  • Colorectal Cancer and Others